INS and Insulin resistance: These findings, unlike those of previous studies that primarily focused on systemic insulin resistance or adipose tissue dysfunction, provide a novel therapeutic target by first demonstrating that blocking the ADM receptor, a microprotein in vascular endothelial cells, restores insulin responsiveness and improves glucose homeostasis [109].